ValueInvesting.io

Research & Analysis — Freemium

Automated DCF and intrinsic value for 45,000+ stocks on 60 global exchanges

Pre-built DCF models for 45,000+ global stocks using Damodaran inputs

Overview

ValueInvesting.io is a research and analysis platform built for long-term investors who want pre-built discounted cash flow valuations instead of building a DCF model from scratch. This ValueInvesting.io review covers a tool that prices more than 45,000 stocks across 60 global exchanges. It's aimed at fundamental investors doing valuation homework before buying and holding.

Coverage is the headline strength here, pulling in public historical data, macro inputs, Professor Damodaran's estimates, and consensus forecasts, with every assumption open to override. The screener itself supports hundreds of metrics beyond the core DCF output, giving investors room to build custom value screens rather than relying on one formula. Paid plans include unlimited export to Excel and Google Sheets, useful for anyone building their own models downstream. The Global plan bundles in API access, letting more technical investors pull valuation data directly into their own systems, and an AI-powered filings search reads across SEC filings and global research documents to speed up the qualitative side of diligence.

Independent validation is thin. Trustpilot shows only two reviews, which isn't much to go on for a service investors are trusting with valuation assumptions. One of those two reviews alleges a strict no-refund billing policy, worth reading closely before entering payment details on an annual plan.

Markets covered span US stocks and global exchanges, with the platform built entirely around long-term investing rather than active trading; there's no day-trading or swing-trading angle here. There's also no mobile app, so this is built for desktop research sessions rather than checking valuations between meetings on a phone. The free plan covers five stocks a month, and a free trial is available on paid tiers for investors who want to test before committing. Traders looking for scanners, real-time alerts, or short-term signals should skip this one; it's a valuation tool, not a trading tool.

Pros

Cons